用白三烯受体拮抗剂扎鲁司特治疗犬异位性皮炎：一项单盲、安慰剂对照研究。
Treatment of canine atopic dermatitis with zafirlukast, a leukotriene-receptor antagonist: a single-blinded, placebo-controlled study.
作者信息
Senter David A, Scott Danny W, Miller William H
机构信息
Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York 14853-6401, USA.
出版信息
Can Vet J. 2002 Mar;43(3):203-6.
Abstract
Zafirlukast and placebo were administered orally as individual agents to 20 dogs with atopic dermatitis. The pruritus was effectively reduced by at least 50% in 2/18 (11%) dogs that completed the trial with zafirlukast. Two dogs vomited after administration of the active drug.
摘要
将扎鲁司特和安慰剂分别口服给予20只患有特应性皮炎的犬。在完成扎鲁司特试验的18只犬中，有2只（11%）的瘙痒症状有效减轻了至少50%。两只犬在服用活性药物后呕吐。
相似文献
1
2
3
Double-blinded, placebo-controlled, cross-over pilot study on the efficacy of zileuton for canine atopic dermatitis.
Vet Dermatol. 2001 Aug;12(4):189-95. doi: 10.1046/j.0959-4493.2001.00254.x.
4
5
Treatment of atopic dermatitis with zafirlukast.
Dermatol Online J. 1999 Nov;5(2):10.
6
The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis.
Arch Dermatol. 1998 Jul;134(7):785-6. doi: 10.1001/archderm.134.7.785.
7
Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (Protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study.0.1%他克莫司软膏（普特彼）治疗犬特应性皮炎的临床疗效与安全性研究：一项随机、双盲、安慰剂对照、交叉研究。
Vet Dermatol. 2004 Oct;15(5):294-303. doi: 10.1111/j.1365-3164.2004.00397.x.
8
A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.一项比较奥克拉替尼和环孢素在控制宠物狗特应性皮炎方面的疗效和安全性的双盲、随机临床试验。
Vet Dermatol. 2015 Feb;26(1):23-30, e7-8. doi: 10.1111/vde.12186. Epub 2014 Dec 12.
9
Cysteinyl-leukotriene receptor antagonism blunts the acute hypotensive response to endotoxin in cats.半胱氨酰白三烯受体拮抗作用可减弱猫对内毒素的急性降压反应。
J Feline Med Surg. 2010 Oct;12(10):754-9. doi: 10.1016/j.jfms.2010.05.012. Epub 2010 Aug 16.
10
Leukotriene receptor antagonists are ineffective for severe atopic dermatitis.白三烯受体拮抗剂对重度特应性皮炎无效。
J Am Acad Dermatol. 2004 Mar;50(3):485-6. doi: 10.1016/s0190-9622(03)00758-8.
本文引用的文献
1
Inability of Short-duration Treatment with a 5-Lipoxy-genase Inhibitor to Reduce Clinical Signs of Canine Atopy.5-脂氧合酶抑制剂短期治疗无法减轻犬特应性皮炎的临床症状。
Vet Dermatol. 1994 Mar;5(1):13-16. doi: 10.1111/j.1365-3164.1994.tb00004.x.
2
Double-blinded, placebo-controlled, cross-over pilot study on the efficacy of zileuton for canine atopic dermatitis.
Vet Dermatol. 2001 Aug;12(4):189-95. doi: 10.1046/j.0959-4493.2001.00254.x.
3
Sulphido-leukotriene production from peripheral leukocytes and skin in clinically normal dogs and house dust mite positive atopic dogs.临床正常犬和屋尘螨阳性特应性犬外周白细胞及皮肤中硫化白三烯的产生情况
Vet Dermatol. 2001 Feb;12(1):3-12. doi: 10.1046/j.1365-3164.2001.00203.x.
4
The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis.白三烯拮抗剂孟鲁司特作为特应性皮炎的治疗药物。
J Am Acad Dermatol. 2001 Jan;44(1):89-93. doi: 10.1067/mjd.2001.111352.
5
Treatment of atopic dermatitis with zafirlukast.
Dermatol Online J. 1999 Nov;5(2):10.
6
A pilot study examining the role of zileuton in atopic dermatitis.一项探讨齐留通在特应性皮炎中作用的初步研究。
Ann Allergy Asthma Immunol. 1999 Dec;83(6 Pt 1):548-52. doi: 10.1016/S1081-1206(10)62868-2.
7
Antihistamines in the management of allergic pruritus in dogs and cats.
J Small Anim Pract. 1999 Aug;40(8):359-64. doi: 10.1111/j.1748-5827.1999.tb03099.x.
8
Chemical mediators in atopic dermatitis: involvement of leukotriene B4 released by a type I allergic reaction in the pathogenesis of atopic dermatitis.特应性皮炎中的化学介质：I型过敏反应释放的白三烯B4在特应性皮炎发病机制中的作用。
J Allergy Clin Immunol. 1999 Apr;103(4):663-70. doi: 10.1016/s0091-6749(99)70240-x.
9
Metabolism and excretion of zafirlukast in dogs, rats, and mice.扎鲁司特在犬、大鼠和小鼠体内的代谢与排泄。
Drug Metab Dispos. 1998 Nov;26(11):1069-76.
10
The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis.
Arch Dermatol. 1998 Jul;134(7):785-6. doi: 10.1001/archderm.134.7.785.
Zotero 插件